DMNQ S-64 Induces Apoptosis via Caspase Activation and Cyclooxygenase-2 Inhibition in Human Nonsmall Lung Cancer Cells

LIM, E.-S.,RHEE, Y.-H.,PARK, M.-K.,SHIM, B.-S.,AHN, K.-S.,KANG, H.,YOO, H.-S.,KIM, S.-H. Wiley (Blackwell Publishing) 2007 Annals of the New York Academy of Sciences Vol.1095 No.1

<P>Shikonin has been reported to induce apoptosis and inhibit angiogenesis in vivo and in vitro. 6-(1-propoxyiminoalkyl)-5,8-dimethoxyoxy 1,4-naphtoquinone S-64 (DMNQ S-64) was synthesized as a shikonin derivative. In this article, the underlying apoptotic mechanism of DMNQ S-64 was examined. DMNQ S-64 exerted cytotoxicity against A549 lung carcinoma cells with IC(50) of 27.3 microM. Apoptotic bodies were observed in DMNQ S-64-treated A549 cells by 4'-6-diamidino-2-phenylindole (DAPI) staining assay. DMNQ S-64 also increased sub-G1 DNA portion in a concentration-dependent manner by flow cytometric analysis. Western blotting has revealed that DMNQ S-64 effectively activates the expression of caspase 8, 9, and 3, cleaves poly (ADP-ribose) polymerase, and increases the ratio of Bax/Bcl-2. Furthermore, cytochrome c was released in a concentration-dependent manner by DMNQ S-64. Similarly, DMNQ S-64 significantly increased caspase 3 activity by enzyme-linked immunosorbent assay (ELISA). It also significantly inhibited the level of prostaglandin E2 (PGE(2)) by ELISA and downregulated the expression of cyclooxygenase-2 (COX-2) in a concentration-dependent manner. Taken together, DMNQ S-64 may exhibit cytotoxicity against A549 cells via caspase activation and COX-2 inhibition.</P>

Supplementation of oil-based inactivated H9N2 vaccine with M2e antigen enhances resistance against heterologous H9N2 avian influenza virus infection

Park, J.K.,Lee, D.H.,Cho, C.H.,Yuk, S.S.,To, E.O.,Kwon, J.H.,Noh, J.Y.,Kim, B.Y.,Choi, S.W.,Shim, B.S.,Song, M.K.,Lee, J.B.,Park, S.Y.,Choi, I.S.,Song, C.S. Elsevier Scientific Pub. Co 2014 Veterinary microbiology Vol.169 No.3

Avian influenza virus (AIV) subtype H9N2 has been evolving rapidly and vaccine escape variants have been reported to cause circulation of infections and economic losses. In the present study, we developed and evaluated ectodomain of the AIV matrix 2 (M2e) protein as a supplementing antigen for oil-based inactivated H9N2 vaccine to increase resistance against vaccine escape variants. AIV H9N2 M2e antigen was expressed in Escherichia coli and supplemented to inactivated H9N2 oil emulsion vaccine. Specific pathogen-free chickens received a single injection of inactivated H9N2 oil emulsion vaccines with or without M2e supplementation. At three weeks post vaccination, hemagglutination inhibition tests and enzyme-linked immunosorbent assays were performed to determine serological immune responses. Challenge study using a vaccine escape H9N2 variant was performed to evaluate the efficacy of M2e supplementation. M2e antigen supplemented in oil emulsion vaccine was highly immunogenic, and a single M2e-supplemented vaccination reduced challenge virus replication and shedding more effectively than non-supplemented vaccination.

H-Y 에 대한 단일클론 항체의 생산 및 그 이용에 관한 연구 1 . H-Y 에 대한 단일클론항체의 생산

심호섭(H . S . Shim),김재화(J . H . Kim),이병철(B . C . Lee),김종배(J . B . Kim),박홍양(H . Y . Park),정길생(K . S . Chung) 한국축산학회 1988 한국축산학회지 Vol.30 No.7

Testis supernatant, a source of H-Y, obtained from BALB/c mice was used to immunize females of same strain. B lymphocytes of mouse producing antibodies to H-Y were fused with SP2/0-Ag 14 myeloma cells and distributed to 384 wells of 96-well microtiter plates. Eighty hybridoma colonies were formed, resulting in 20.8 percent of fusion efficiency. Three strong positive wells from hybridoma colonies were selected for cloning by ELISA and two of them were also found to be positive by indirect immunofluorescence test. Twelve wells of ELISA-positive were selected after cloning and 2D45D4 clones from them were confirmed to produce monoclonal antibodies to H-Y by indirect immunofluorescence test.

S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis

Kim, S Y,S Hong, Y,K Shim, E,Kong, S-Y,Shin, A,Baek, J Y,Jung, K H Nature Publishing Group 2013 The British journal of cancer Vol.109 No.6

<P><B>Background:</B></P><P>S-1 is an oral fluoropyrimidine that mimics infusional 5-fluorouracil. The aim of this phase II trial was to explore the clinical efficacy of the triplet regimen TIROX, which consists of S-1, irinotecan and oxaliplatin.</P><P><B>Methods:</B></P><P>Forty-two chemo-naive patients with metastatic colorectal cancer (mCRC) were planned to be enrolled and be treated with irinotecan 150 mg m<SUP>−2</SUP> followed by oxaliplatin 85 mg m<SUP>−2</SUP> on day 1 and S-1 80 mg m<SUP>−2</SUP> per day from day 1 to 14 every 3 weeks. Polymorphisms in the <I>UGT1A1</I>, <I>UGT1A6</I>, <I>UGT1A7</I> and <I>CYP2A6</I> genes were analysed.</P><P><B>Results:</B></P><P>Between July 2007 and February 2008, 43 patients were enrolled. An objective response was noted in 29 patients (67.4%, 95% confidence interval: 53.4–81.4), of which 2 achieved durable complete responses. The median progression-free survival was 10.0 months and the median overall survival was 19.2 months. Significant grade 3 or 4 adverse events were neutropenia (45.2%), febrile neutropenia (9.5%), diarrhoea (7.1%) and vomiting (9.5%). Increased gastrointestinal toxicities were associated with the presence of <I>UGT1A6*2</I> or <I>UGT1A7*3</I> and an improved tumour response was noted in those without variant alleles of <I>CYP2A6</I> or <I>UGT1A1*60</I>.</P><P><B>Conclusion:</B></P><P>The combination of S-1, irinotecan and oxaliplatin showed favourable efficacy and tolerability in untreated patients with mCRC.</P>

z-방향으로 비등방적인 원통형 결함을 가진 YBCO 단결정의 자속운동

심성엽,황태종,김동호 嶺南大學校 基礎科學 硏究所 1998 基礎科學硏究 Vol.18 No.-

We have made a comparison of the magnetic properties between columnar defect introduced YBCO single crystal(S#1) and partially introduced crystal(S#2).Magnetization vs. applied field curves of S#1 had larger width than S#2 by SQUID magnetometer measurement. But if we considered the volume of partially introduce columnar defect in S#2, the curves of magntization of S#1 and S#2 showed nearly same magnitude. Moreover, S#1 and S#2 showed same normalized relaxation rate thus we may concluded that only the part of columnar defect contrubute the flux pinning in S#2. Irreversibility line(IRL)was obtained from AC susceptibility measurement. IRL of S#2 showed downward shift relative to the case of S31. Below the Bcr, exponent αwas 1.85 and 1.68 in the S#2, respectively. Bose-glass phase was even showed in the case of S#2 defect structure.

Three-dimensional spin configuration of ferromagnetic nanocubes.

Piao, H-G,Djuhana, D,Shim, J-H,Lee, S-H,Jun, S-H,Oh, S K,Yu, S-C,Kim, D-H American Scientific Publishers 2010 Journal of Nanoscience and Nanotechnology Vol.10 No.11

<P>We have systematically investigated three-dimensional spin configurations in ferromagnetic nanocubes using micromagnetic simulation with variation of cube geometry. For thin cuboids, a spin configuration exhibits a four-domain Landau state with a magnetic vortex structure at the center as in the case of a thin film square. For a thick cube, a complex spin configuration with an S-type cylindrically asymmetric vortex having two cores on a pair of surfaces while a leaf-like and a C-type states are observed on the other two pairs of cube surfaces. Competition between the geometrical symmetry and magnetic energy minimization condition in ferromagnetic nanocubes leads to the complex spin structure with a spontaneously broken symmetry.</P>

受精能獲得精子와 山羊卵子의 體外受精에 관한 硏究

송해범,심금섭 대구대학교 농업과학연구소 1987 農業科學硏究論文集 Vol.1 No.-

Ejaculated and/or epididymal spermatozoa of goats were preincubated for 4-6 h in the isolated genital tracts from hamsters, gilts and goats, or for 3-8 h in m-KRB solution. After preincubation, they inseminated the goat ovulated eggs collected shortly after ovulation and/or the follicular oocytes with intact and without cumulus cells cultured for 25 h in m-KRB solution, and the oocytes with dispersed cumulus cells which were not cultured. The results obtained were as follows. (1) None of the ovulated eggs were fertilized after insemination with ejaculated and epididymal spermatozoa preincubated for 4-5 h in the isolated genital tracts from hamsters, gilts and goats. But 50 and 38% of the ovulated eggs were fertilized with epididymal sermatozoa preincubated for 5 and 6 h in m-KRB solution, respectively. (2) None of the follicular oocytes were fertilized after insemination with ejaculated spermatozoa preincubated for 4-6 h in the uteri isolated from hamsters and goats, and with epididymal spermatozoa preincubated for 4-6 h in the isolated hamster uterus. But 38% of the follicular oocytes were fertilized with epididymal spermatozoa preincubated for 5 h in the isolated goat uterus. (3) After further culture with spermatozoa for 18-24 h, 50-89, 89 and 14-33% of the oocytes with intact, with dispersed and without cumulus cells had matured to the second metaphase, respectively. (4) When epididymal spermatozoa were preincubated for 5 h at the concentration of 4.2x10^(8)/ml and 6 h at the concentration of 3.5x10^(8)/ml in m-KRB solution, 36 and 33% of the oocytes with intact cumulus cells were fertilized. (5) The results suggested that epididymal spermatozoa can be capacitated in m-KRB solution, and that the follicular oocytes matured in culture could be used for the study of fertilization in vitro instead of the ovulated eggs.

MSP430 기반 뇌신경자극기 S/W 설계 및 구현

홍상표(S. P. Hong),권성호(C. H. Quan),심현민(H. M. Shim),김규태(K. T. Kim),김규성(K. S. Kim),윤광섭(K. S. Yoon),이상민(S. M. Lee) 한국재활복지공학회 2015 한국재활복지공학회 학술대회논문집 Vol.2015 No.11

This paper presents the results of the neuromodulation S/W Design and Implementation based on MSP430. The MSP430 operating with ultra power is used actively in the development of human implantable devices. In this paper, The neuromodulation S/W that was designed based on MSP430 has a simple architecture. Also, this neuromodulation S/W provides the reliability and scalability of generating neuro signals simultaneously. In order to verify the operation of the neuromodulation S/W, A separate external control device(PC) test program developed. By using the program, The experiments on generating and controling a brain stimulation signals corresponding to the parameter was conducted and shows the results.

생쥐수정란에 대한 H - Y 항체처리가 산자의 성비에 미치는 영향

심호섭,고정재,김종배,박홍양,정길생 ( H . S . Shim,J . J . Ko,J . B . Kim,H . Y . Park,K . S . Chung ) 한국축산학회 1986 한국축산학회지 Vol.28 No.12

These experiments were carried out to control the sex of offsprings in mice by sexing embryos using immunological means prior to transfer to pseudopregnant recipients. H-Y antisera were prepared in inbred SD female rats by repeated immunization of testis supernatant and spleen cells from males of same strain. ELISA and indirect immunofluorescence test were used to detect H-Y antibody in antisera. Eight- to 16-cell mouse embryos were cultured in medium with H-Y antibody and complement (treated embryos) and in medium with BSA (control embryos). After 24-48 hr of culture, embryos were observed their morphological characteristics under the phase contrast microscope. Embryos developed to normal blastocyst were transferred to pseudopregnant recipients and sex of resultant offspring was investigated. The results obtained in these experiments were summarized as follows: 1. Production of H-Y antibodies in antisera obtained from immunized rats was confimed by ELISA and indirect immunofluorescence test. 2. Of 270 embryos treated with H-Y antibody and complement, 126 embryos (46.7%) were developed to normal blastocysts. 3. Following transfer of 126 blastocysts, 16 embryos (12.6%) were survived to term and 13 females (81.3%), significantly high ratio of female offspring, were produced.

Pharmacokinetics and Mammary Residual Depletion of Erythromycin in Healthy Lactating Ewes

Goudah, A.,Sher Shah, S.,Shin, H.C.,Shim, J.H.,Abd El-Aty, A. M. Blackwell Publishing Ltd 2007 Journal of veterinary medicine. A, Physiology, pat Vol.54 No.10

<P>Summary</P><P>The aim of this investigation was to examine the pharmacokinetics and mammary excretion of erythromycin administered to lactating ewes (<I>n</I> = 6) by the intravenous (i.v.), intramuscular (i.m.) and subcutaneous (s.c.) routes at a dosage of 10 mg/kg. Blood and milk samples were collected at pre-determined times, and a microbiological assay method was used to measure erythromycin concentrations in serum and milk. The concentration–time data were analysed by compartmental and non-compartmental kinetic methods. The serum concentration–time data of erythromycin were fit to a two-compartment model after i.v. administration and a one-compartment model with first-order absorption after i.m. and s.c. administration. The elimination half-life (<I>t</I><SUB>1/2&bgr;</SUB>) was 4.502 ± 1.487 h after i.v. administration, 4.874 ± 0.296 h after i.m. administration and 6.536 ± 0.151 h after s.c. administration. The clearance value (Cl<SUB>tot</SUB>) after i.v. dosing was 1.292 ± 0.121 l/h/kg. After i.m. and s.c. administration, observed peak erthyromycin concentrations (<I>C</I><SUB>max</SUB>) of 0.918 ± 0.092 <I>&mgr;</I>g/ml and 0.787 ± 0.010 <I>&mgr;</I>g/ml were achieved at 0.75 and 1.0 h (<I>T</I><SUB>max</SUB>) respectively. The bioavailability obtained after i.m. and s.c. administration was 91.178 ± 10.232% and 104.573 ± 9.028% respectively. Erythromycin penetration from blood to milk was quick for all the routes of administration, and the high AUC<SUB>milk</SUB>/AUC<SUB>serum</SUB> (1.186, 1.057 and 1.108) and C<SUB>max‐milk</SUB>/C<SUB>max‐serum</SUB> ratios reached following i.v., i.m. and s.c. administration, respectively, indicated an extensive penetration of erythromycin into the milk.</P>